What medications can I use to increase my breastmilk supply?
The two medications most often used off-label to boost milk supply are domperidone and metoclopramide, but evidence for how well they work is weak, and both carry real safety concerns, so they're normally tried only after other feeding support hasn't helped.
In Canada, domperidone is the medication most commonly prescribed for this purpose, while metoclopramide is used more in some other countries but has more bothersome side effects.
Mixed
A Cochrane systematic review found only low-certainty evidence that these drugs increase milk volume, based on small trials; safety data come mostly from cohort studies and case reports rather than large RCTs.
What the evidence says
The main medications used to try to increase milk supply are domperidone and metoclopramide. Both work by raising prolactin, the hormone that drives milk production, but neither is officially approved in Canada or the US specifically for this use — they're prescribed off-label.
A Cochrane review looking at domperidone, metoclopramide and sulpiride found they may increase milk volume by a modest amount, but rated the evidence as low-certainty, based on only a few small studies. Domperidone tends to have fewer side effects than metoclopramide, which has been linked to depression, tiredness, and involuntary movements in a meaningful proportion of mothers who take it.
Domperidone itself isn't risk-free: it can rarely cause serious heart rhythm problems, especially at higher doses, and Health Canada has flagged that stopping it abruptly or tapering it can trigger anxiety, insomnia or a return of mental health symptoms in some women. Because of this, guidance generally says to first make sure feeding technique, frequency, and any underlying maternal or infant issues are addressed, and to only consider medication with your doctor's guidance if supply is still a problem afterward.
If you're worried about your supply, it's worth talking to your doctor or a lactation consultant first — they can check for correctable causes before considering medication, and can weigh the modest possible benefit against the known risks for your situation.
Sources
-
Systematic review
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants
Cochrane Database of Systematic Reviews (PubMed), 2020
Systematic review: low-certainty evidence galactagogues modestly increase milk volume
-
Guideline
Domperidone and psychiatric withdrawal events when used off-label for lactation stimulation
Health Canada, Health Product InfoWatch, 2023
Canadian safety advisory on domperidone withdrawal and mental health risks
-
Guideline
Pregnancy, breastfeeding and fertility while taking metoclopramide
NHS, 2024
National guidance on metoclopramide use during breastfeeding
-
Expert organisation
Metoclopramide
MotherToBaby, 2026
Expert fact sheet: evidence for metoclopramide boosting supply is mixed
-
Systematic review
Use of domperidone as a galactagogue drug: a systematic review of the benefit-risk ratio
PubMed, 2014
Review weighing modest efficacy against rare cardiac risks
-
Systematic review
Health Canada advisory on domperidone: Should I avoid prescribing domperidone to women to increase milk production?
Canadian Family Physician (PubMed), 2012
Discusses meta-analysis showing prolactin/supply increase and safety context
✓Reviewed by CH, MD, FRCPC
Reviewed by a specialist physician certified by the Royal College of Physicians and Surgeons of Canada, who has read this answer against the sources listed above and confirmed it reflects them. That is not medical advice about your child. How we review
Answer checked July 29, 2026